Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of GLPG1972 Oral Tablet vs Solution
NCT02851485Phase 1Completed
- Sponsor
- Galapagos NV
- Start
- Jul 2016
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of GLPG1972 in osteoarthritis (OA) (3 arms), sponsored by Galapagos NV. Primary endpoints: Maximum observed plasma concentration, Plasma concentration 24 hours after dosing and 8 more. Started Jul 2016; status: completed.
02
Drugs
GLPG1972
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02851485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02851485.